The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Homocysteine and brain atrophy on MRI of non-demented elderly
Open accessAbstract
Patients with Alzheimer's disease have higher plasma homocysteine levels than controls, but it is uncertain whether higher plasma homocysteine levels are involved in the early pathogenesis of the disease. Hippocampal, amygdalar and global brain atrophy on brain MRI have been proposed as early markers of Alzheimer's disease. In the Rotterdam Scan Study, a population-based study of age-related brain changes in 1077 non-demented people aged 60-90 years, we investigated the association between plasma homocysteine levels and severity of hippocampal, amygdalar and global brain atrophy on MRI. We used axial T(1)-weighted MRIs to visualize global cortical brain atrophy (measured semi-quantitatively; range 0-15) and a 3D HASTE (half-Fourier acquisition single-shot turbo spin echo) sequence in 511 participants to measure hippocampal and amygdalar volumes. We had non-fasting plasma homocysteine levels in 1031 of the participants and in 505 of the participants with hippocampal and amygdalar volumes. Individuals with higher plasma homocysteine levels had, on average, more cortical atrophy [0.23 units (95% CI 0.07-0.38 units) per standard deviation increase in plasma homocysteine levels] and more hippocampal atrophy [difference in left hippocampal volume -0.05 ml (95% CI -0.09 to -0.01) and in right hippocampal volume -0.03 ml (95% CI -0.07 to 0.01) per standard deviation increase in plasma homocysteine levels]. No association was observed between plasma homocysteine levels and amygdalar atrophy. These results support the hypothesis that higher plasma homocysteine levels are associated with more atrophy of the hippocampus and cortical regions in elderly at risk of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
Self-citationAssociation between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Determinants of disease and disability in the elderly: The Rotterdam elderly study
Hofman, A., Grobbee, D. E., De Jong, P. T. V. M., & Van den Ouweland, F. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00145007 · Cited by 1,129
Self-citationRates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
Neurotoxicity associated with dual actions of homocysteine at the N -methyl- d -aspartate receptor
Lipton, S. A., Kim, W.-K., Choi, Y.-B., Kumar, S., D’Emilia, D. M., Rayudu, P. V., Arnelle, D. R., & Stamler, J. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5923 · Cited by 847
Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., & Mattson, M. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06920.2000 · Cited by 784
Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003) · Stroke · doi:10.1161/01.str.0000052631.98405.15 · Cited by 680
Self-citationThe Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI
Duvernoy, H. M., Cattin, F., & Risold, P.-Y. (2013) · Springer eBooks · doi:10.1007/978-3-642-33603-4 · Cited by 561
Research works printed but not linked: 1
- de Groot, 2000, Annals of neurology, 47, 145, 10.1002/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P · doi:10.1002/1531-8249(200002)47:2<145::aid-ana3>3.0.co;2-p
Cited by
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910
Vitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
“Raised tHcy is also associated with both regional and whole brain atrophy, not only in Alzheimer’s disease [12] but also in healthy elderly [17,18,19,20,21].”
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
Homocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 513
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Obeid, R., & Herrmann, W. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.088 · Cited by 490
MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders
Geuze, E., Vermetten, E., & Bremner, J. D. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001579 · Cited by 412
Liu-Ambrose, T., Nagamatsu, L. S., Voss, M. W., Khan, K. M., & Handy, T. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.010 · Cited by 363
Modifiable factors that alter the size of the hippocampus with ageing
Fotuhi, M., Do, D., & Jack, C. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.27 · Cited by 356
Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M., & Lucca, U. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.114 · Cited by 339
Homocysteine and Alzheimer's disease
Morris, M. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00438-1 · Cited by 332
Cardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 322
Vrooman, H. A., Cocosco, C. A., van der Lijn, F., Stokking, R., Ikram, M. A., Vernooij, M. W., Breteler, M. M. B., & Niessen, W. J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.05.018 · Cited by 314
Self-citationTherapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284
den Heijer, T., Geerlings, M. I., Hoebeek, F. E., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.57 · Cited by 258
Self-citationGeerlings, M. I., den Heijer, T., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000308937.30473.d1 · Cited by 248
Self-citationden Heijer, T., van der Lijn, F., Koudstaal, P. J., Hofman, A., van der Lugt, A., Krestin, G. P., Niessen, W. J., & Breteler, M. M. B. (2010) · Brain · doi:10.1093/brain/awq048 · Cited by 227
Self-citationDiet, cognition, and alzheimer’s disease: food for thought
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214
Plasma homocysteine levels and risk of Alzheimer disease
Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129504.60409.88 · Cited by 171
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease
Peters, N., Holtmannspötter, M., Opherk, C., Gschwendtner, A., Herzog, J., Sämann, P., & Dichgans, M. (2006) · Neurology · doi:10.1212/01.wnl.0000216271.96364.50 · Cited by 130
Albumin and multiple sclerosis
LeVine, S. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0564-9 · Cited by 105
Elias, M. F., Robbins, M. A., Budge, M. M., Elias, P. K., Brennan, S. L., Johnston, C., Nagy, Z., & Bates, C. J. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221380.92521.51 · Cited by 94
Ma, F., Li, Q., Zhou, X., Zhao, J., Song, A., Li, W., Liu, H., Xu, W., & Huang, G. (2019) · European Journal of Nutrition · doi:10.1007/s00394-017-1598-5 · Cited by 90
“By contrast with other trials, folic acid supplementation might beneficially affect both memory and speed simultaneously [17], and high concentrations of Hcy have been associated with atrophy of the hippocampus, an area of the brain which is important for memory consolidation [31].”
ResultQin, B., Xun, P., Jacobs, D. R., Zhu, N., Daviglus, M. L., Reis, J. P., Steffen, L. M., Van Horn, L., Sidney, S., & He, K. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157834 · Cited by 77
Plasma Homocysteine and Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Miller, J., Green, R., & Luchsinger, J. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000182421 · Cited by 38
Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
Daulatzai, M. A. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9528-x · Cited by 12
“In a study of 1077 individuals without dementia (60–90 years old), elevated plasma homocysteine was associated with hippocampal atrophy (den Heijer et al. 2003; Firbank et al. 2010).”
Background
Metadata
- Authors
- den Heijer, T., Vermeer, S. E., Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 126
- Issue
- 1
- Pages
- 170-175
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2111185373
- Cited by
- 282
- References
- 27
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.